AGIOS PHARMACEUTICALS, INC. (AGIO) Gross margin 2016–2025
AGIOS PHARMACEUTICALS, INC. (AGIO) gross margin by fiscal year — reported gross profit divided by reported revenue.
88.3%FY2025 · since FY2016: 100.0% → 88.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 88.3% | -0.3 pp |
| FY2024 | 88.6% | -0.7 pp |
| FY2023 | 89.3% | +1.2 pp |
| FY2022 | 88.0% | — |
| FY2019 | 98.9% | +0.4 pp |
| FY2018 | 98.5% | -1.5 pp |
| FY2017 | 100.0% | +0.0 pp |
| FY2016 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice